Barclays lowered CVS Health (NYSE:CVS) price target from $100 to $90

By / / Barclays, CVS Health

Barclays analyst Steve Valiquette maintains CVS Health (NYSE:CVS) with a Overweight and lowers the price target from $100 to $90.

Scroll to Top